Resveratrol researcher faked data, report says; what drives academic fraud?
Los Angeles Times:
A University of Connecticut researcher who worked on the health benefits of a chemical in red wine fabricated data in 145 separate research projects, a three-year investigation has found.
University officials have notified 11 scientific journal studies co-authored by Dipak Das, whose work focused on whether resveratrol — an antioxidant found in grape skin — can prevent coronary heart disease or kill cancer cells, according to the Boston Herald.
Resveratrol has been linked to these benefits in a number of studies — just recently, Times health writer Melissa Healy explained a study that showed obese men who took resveratrol in high doses saw their metabolic function improve and evidence of inflammation fall — almost as if they were becoming more “athletic” without raising a single dumbbell.
Read the whole story: Los Angeles Times
Comments
Reporters are parroting what the University of Connecticut issued without obtaining Dr. Das’ side of the story. The U CONN report has many discrepancies in it. For example, the informant in this case had keys to Dr Das’ office while the university claims only Dr Das had keys.
APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.
Please login with your APS account to comment.